What is the connection between apelisib and alpelisib

The connection between Alpelisib and alpelisib is direct and clear: they are two different ways of saying the same drug.

Judging from the name,"alpelisib" is the Chinese name, while "alpelisib" is the English name of the drug. They refer to the same drug, a PI3K inhibitor, used to treat certain types of breast cancer. From the perspective of drug attributes and applications, whether it is apelisib or alpelisib, they refer to the same PI3K inhibitor and have the same pharmacological effects and therapeutic effects. This drug is particularly suitable for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced or metastatic breast cancer with PIK3CA gene mutations.

Apelix, as the Chinese name of the drug, is easier for Chinese users to understand and remember. This name may have been given when the drug entered the Chinese market or when Chinese-related research was conducted to conform to the Chinese context and habits. Andalpelisib is the international common name of the drug, which is the English name. This English name is commonly used to refer to this drug in scientific research, international communication, and in much of the international medical literature.

In general, the connection between alpelisib andalpelisib is that they both refer to the same drug, but they are expressed in different languages. The former is a Chinese name and is more suitable for use in a Chinese environment; the latter is an English name and is more commonly used in scientific research. Regardless of which name is used, the properties and therapeutic effects of the drug they represent are the same.

In addition, although Apelvis has been widely used and recognized overseas, it has not yet received marketing approval in China. Therefore, Chinese patients need to be cautious when choosing to use this drug and consult professional doctors for advice.